Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017–CIIL - Centre for Infection and Immunity of LilleLille, Haute-Normandie, France
Disclosure(s): ILiAD biotechnologies: Advisor/Consultant, Grant/Research Support
596 - Immunogenicity and Safety of BPZE1, an Intranasal Live Attenuated Pertussis Vaccine, Evaluated With and Without Tdap in Healthy Children 6 to 17 Years Old: A Phase 2b, Randomized, Active-Controlled Study
Saturday, October 19, 20242:45 PM – 3:00 PM US PT
